Table of Contents 1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Overview 1.1 Product Overview and Scope of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors 1.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Type 1.2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 Nesina 1.2.3 Tradjenta 1.2.4 Onglyza 1.2.5 Januvia 1.2.6 Others 1.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Segment by Application 1.3.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Comparison by Application: 2020 VS 2026 1.3.2 Type 2 Diabetes 1.3.3 Others 1.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Estimates and Forecasts 1.4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue 2015-2026 1.4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales 2015-2026 1.4.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Region: 2020 Versus 2026 2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competition by Manufacturers 2.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Manufacturers (2015-2020) 2.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2015-2020) 2.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Sites, Area Served, Product Type 2.5 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Competitive Situation and Trends 2.5.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players (Opinion Leaders) 3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario by Region 3.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country 3.3.1 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.3.2 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country 3.4.1 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.4.2 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Region 3.5.1 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region 3.5.2 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country 3.6.1 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.6.2 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Facts & Figures by Country 3.7.1 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.7.2 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Historic Market Analysis by Type 4.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type (2015-2020) 4.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Type (2015-2020) 4.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price Market Share by Type (2015-2020) 4.4 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Historic Market Analysis by Application 5.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020) 5.2 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Application (2015-2020) 5.3 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price by Application (2015-2020) 6 Company Profiles and Key Figures in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Business 6.1 Sanofi 6.1.1 Corporation Information 6.1.2 Sanofi Description, Business Overview and Total Revenue 6.1.3 Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Sanofi Products Offered 6.1.5 Sanofi Recent Development 6.2 Takeda 6.2.1 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.2.2 Takeda Description, Business Overview and Total Revenue 6.2.3 Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.2.4 Takeda Products Offered 6.2.5 Takeda Recent Development 6.3 Eli Lilly 6.3.1 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.3.2 Eli Lilly Description, Business Overview and Total Revenue 6.3.3 Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Eli Lilly Products Offered 6.3.5 Eli Lilly Recent Development 6.4 Merck 6.4.1 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.4.2 Merck Description, Business Overview and Total Revenue 6.4.3 Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Merck Products Offered 6.4.5 Merck Recent Development 6.5 Novo Nordisk 6.5.1 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.5.2 Novo Nordisk Description, Business Overview and Total Revenue 6.5.3 Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Novo Nordisk Products Offered 6.5.5 Novo Nordisk Recent Development 6.6 Bristol-Myers Squibb 6.6.1 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.6.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue 6.6.3 Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.6.4 Bristol-Myers Squibb Products Offered 6.6.5 Bristol-Myers Squibb Recent Development 6.7 Pfizer 6.6.1 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.6.2 Pfizer Description, Business Overview and Total Revenue 6.6.3 Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.4.4 Pfizer Products Offered 6.7.5 Pfizer Recent Development 6.8 AstraZeneca 6.8.1 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.8.2 AstraZeneca Description, Business Overview and Total Revenue 6.8.3 AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.8.4 AstraZeneca Products Offered 6.8.5 AstraZeneca Recent Development 6.9 GlaxoSmithKline 6.9.1 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.9.2 GlaxoSmithKline Description, Business Overview and Total Revenue 6.9.3 GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.9.4 GlaxoSmithKline Products Offered 6.9.5 GlaxoSmithKline Recent Development 6.10 Boehringer Ingelheim 6.10.1 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Production Sites and Area Served 6.10.2 Boehringer Ingelheim Description, Business Overview and Total Revenue 6.10.3 Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Boehringer Ingelheim Products Offered 6.10.5 Boehringer Ingelheim Recent Development 7 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturing Cost Analysis 7.1 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors 7.4 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List 8.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2021-2026) 10.2 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2021-2026) 10.3 Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Region (2021-2026) 10.4 North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Estimates and Projections (2021-2026) 10.5 Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Estimates and Projections (2021-2026) 10.6 Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Estimates and Projections (2021-2026) 10.7 Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Estimates and Projections (2021-2026) 10.8 Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Growth Rate Comparison by Type (2015-2026) Table 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Comparison by Application: 2020 VS 2026 Table 3. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size by Type (K MT) (US$ Million) (2020 VS 2026) Table 4. Global Key Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Covered in This Study Table 5. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Manufacturers (2015-2020) Table 6. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers (2015-2020) Table 7. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Average Price (USD/MT) of Key Manufacturers (2015-2020) Table 10. Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Sites and Area Served Table 11. Manufacturers Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Product Types Table 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dipeptidyl Peptidase-4 (DPP-4) Inhibitors as of 2019) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Players Table 16. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Region (2015-2020) Table 17. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2015-2020) Table 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) by Region (2015-2020) Table 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2015-2020) Table 20. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2015-2020) (K MT) Table 21. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020) Table 22. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 23. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020) Table 24. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2015-2020) (K MT) Table 25. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020) Table 26. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Region (2015-2020) (K MT) Table 29. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2015-2020) Table 32. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2015-2020) (K MT) Table 33. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020) Table 34. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales by Country (2015-2020) (K MT) Table 37. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country (2015-2020) Table 40. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Type (2015-2020) Table 41. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Type (2015-2020) Table 42. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) by Type (2015-2020) Table 43. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Type (2015-2020) Table 44. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Price (USD/MT) by Type (2015-2020) Table 45. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) by Application (2015-2020) Table 46. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020) Table 47. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate by Application (2015-2020) Table 48. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 49. Sanofi Description and Business Overview Table 50. Sanofi Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 51. Sanofi Main Product Table 52. Sanofi Recent Development Table 53. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 54. Takeda Corporation Information Table 55. Takeda Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 56. Takeda Main Product Table 57. Takeda Recent Development Table 58. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 59. Eli Lilly Corporation Information Table 60. Eli Lilly Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 61. Eli Lilly Main Product Table 62. Eli Lilly Recent Development Table 63. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 64. Merck Corporation Information Table 65. Merck Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 66. Merck Main Product Table 67. Merck Recent Development Table 68. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 69. Novo Nordisk Corporation Information Table 70. Novo Nordisk Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 71. Novo Nordisk Main Product Table 72. Novo Nordisk Recent Development Table 73. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 74. Bristol-Myers Squibb Corporation Information Table 75. Bristol-Myers Squibb Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 76. Bristol-Myers Squibb Main Product Table 77. Bristol-Myers Squibb Recent Development Table 78. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 79. Pfizer Corporation Information Table 80. Pfizer Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 81. Pfizer Main Product Table 82. Pfizer Recent Development Table 83. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 84. AstraZeneca Corporation Information Table 85. AstraZeneca Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 86. AstraZeneca Main Product Table 87. AstraZeneca Recent Development Table 88. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 89. GlaxoSmithKline Corporation Information Table 90. GlaxoSmithKline Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 91. GlaxoSmithKline Main Product Table 92. GlaxoSmithKline Recent Development Table 93. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Corporation Information Table 94. Boehringer Ingelheim Corporation Information Table 95. Boehringer Ingelheim Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT), Revenue (Million US$), Price (USD/MT) and Gross Margin (2015-2020) Table 96. Boehringer Ingelheim Main Product Table 97. Boehringer Ingelheim Recent Development Table 98. Sales Base and Market Concentration Rate of Raw Material Table 99. Key Suppliers of Raw Materials Table 100. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Distributors List Table 101. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Customers List Table 102. Market Key Trends Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 104. Key Challenges Table 105. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Forecast by Type (2021-2026) Table 106. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Type (2021-2026) Table 107. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) Forecast by Type (2021-2026) Table 108. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 109. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Forecast by Application (2021-2026) Table 110. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) Forecast by Application (2021-2026) Table 111. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) Forecast by Region (2021-2026) Table 112. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share Forecast by Region (2021-2026) Table 113. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Forecast by Region (2021-2026) (US$ Million) Table 114. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share Forecast by Region (2021-2026) Table 115. Research Programs/Design for This Report Table 116. Key Data Information from Secondary Sources Table 117. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Figure 2. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Type: 2020 VS 2026 Figure 3. Nesina Product Picture Figure 4. Tradjenta Product Picture Figure 5. Onglyza Product Picture Figure 6. Januvia Product Picture Figure 7. Others Product Picture Figure 8. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Consumption Market Share by Application: 2020 VS 2026 Figure 9. Type 2 Diabetes Figure 10. Others Figure 11. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size 2015-2026 (US$ Million) Figure 12. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Capacity (K MT) (2015-2026) Figure 13. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Share by Manufacturers in 2020 Figure 15. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue in 2019 Figure 17. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region (2015-2020) Figure 19. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region in 2019 Figure 20. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region (2015-2020) Figure 21. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region in 2019 Figure 22. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2019 Figure 23. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019 Figure 24. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 25. U.S. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 27. Canada Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2019 Figure 29. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019 Figure 30. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 31. Germany Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 33. France Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 35. U.K. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 37. Italy Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 39. Russia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Region in 2019 Figure 41. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Region in 2019 Figure 42. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 43. China Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 45. Japan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 47. South Korea Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 49. India Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 51. Australia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 53. Taiwan Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 55. Indonesia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 57. Thailand Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 59. Malaysia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 61. Philippines Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 63. Vietnam Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2019 Figure 65. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019 Figure 66. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 67. Mexico Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 69. Brazil Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 71. Argentina Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Market Share by Country in 2019 Figure 74. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 75. Turkey Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 77. Saudi Arabia Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth Rate (2015-2020) (K MT) Figure 79. U.A.E Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2015-2020) Figure 81. Sales Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type in 2019 Figure 82. Revenue Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type (2015-2020) Figure 83. Revenue Market Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Type in 2019 Figure 84. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Growth by Type (2015-2020) (K MT) Figure 85. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application (2015-2020) Figure 86. Global Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application (2015-2020) Figure 88. Global Revenue Share of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors by Application in 2020 Figure 89. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. Takeda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Novo Nordisk Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. GlaxoSmithKline Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Price Trend of Key Raw Materials Figure 100. Manufacturing Cost Structure of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Figure 101. Manufacturing Process Analysis of Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Figure 102. Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Industrial Chain Analysis Figure 103. Channels of Distribution Figure 104. Distributors Profiles Figure 105. Porter's Five Forces Analysis Figure 106. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 107. North America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 108. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 109. Europe Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 110. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 111. Latin America Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 112. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 113. Middle East and Africa Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 114. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Sales (K MT) and Growth Rate Forecast (2021-2026) Figure 115. Asia Pacific Dipeptidyl Peptidase-4 (DPP-4) Inhibitors Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Bottom-up and Top-down Approaches for This Report Figure 117. Data Triangulation Figure 118. Key Executives Interviewed

Sanofi Takeda Eli Lilly Merck Novo Nordisk Bristol-Myers Squibb Pfizer AstraZeneca GlaxoSmithKline Boehringer Ingelheim